Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Cancer Cell 41 , 434449 (2023)
Bar-Or, D., Curtis, C
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial
Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization
Disclaimer: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research professional use only
peptide profile and pharmacology
US$ 22.42
US$ 23.69
US$ 23.55
